Coral Raises $4 Million in Latest Funding Round
Coral, a Montreal-based virtual care clinic, has successfully raised $4 million in its latest funding round. The round was led by a consortium of investors including Brightspark, Diagram, AQC Capital, Anges Quebec, and The51. Coral specializes in providing personalized, evidence-based support for individuals experiencing perimenopause and menopause, as well as offering services focused on weight loss and longevity.
Company Background
Coral was co-founded by Anna Chif, who serves as the Chair of the Board, alongside Fiona Lake Waslander, the CEO, and John McCalla, the CTO. The company aims to address the often-overlooked healthcare needs of individuals undergoing perimenopausal and menopausal changes by offering tailored virtual care solutions.
Details of the Funding Round
The funding round, which took place on March 31, 2026, was not disclosed as a specific series but involved significant participation from prominent investors. Brightspark, Diagram, AQC Capital, Anges Quebec, and The51 led the investment, highlighting their interest in innovative healthcare solutions.
Strategic Plans for the New Capital
While the specific allocation of the new funds was not detailed, it is anticipated that Coral will use this capital injection to expand its service offerings and potentially widen its reach geographically. The investment will likely support technological enhancements to their platform, enabling more comprehensive and personalized care for their users.
Leadership Perspectives
Fiona Lake Waslander, Coral’s CEO, emphasized the importance of the funding in advancing their mission to provide accessible and personalized healthcare. "This investment will allow us to enhance our service offerings and reach more individuals who can benefit from our support," she stated.
Conclusion
With this latest funding, Coral is well-positioned to continue its growth trajectory in the virtual healthcare space. The support from a diverse group of investors underscores the confidence in Coral's approach to addressing critical health needs associated with menopause and longevity.